Shandong Weigao Group Medical Polymer Company Limited
Symbool: SHWGF
PNK
0.9575
USDMarktprijs vandaag
15.4080
Koers/Winst Verhouding
0.0000
Koers/Winst Groei Verhouding
4.33B
MRK Kapitalisatie
- 0.02%
DIV Rendement
Shandong Weigao Group Medical Polymer Company Limited (SHWGF) Jaarrekeningen
Balans
common:word.in-mln USD Growth | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | |||
---|---|---|---|---|---|---|---|---|---|
balance-sheet.row.cash-and-short-term-investments | 0 | 1140.1 | 1157.2 | 1238.3 | |||||
balance-sheet.row.short-term-investments | 0 | 48.6 | 71.2 | 68.3 | |||||
balance-sheet.row.net-receivables | 0 | 1039.3 | 1016.6 | 963.4 | |||||
balance-sheet.row.inventory | 0 | 351.7 | 332.8 | 279.5 | |||||
balance-sheet.row.other-current-assets | 0 | 95.6 | 93.4 | 69.3 | |||||
balance-sheet.row.total-current-assets | 0 | 2626.7 | 2600 | 2550.5 | |||||
balance-sheet.row.property-plant-equipment-net | 0 | 1034 | 1051 | 1055.1 | |||||
balance-sheet.row.goodwill | 0 | 525.5 | 523 | 525.2 | |||||
balance-sheet.row.intangible-assets | 0 | 1507.3 | 770.5 | 807.4 | |||||
balance-sheet.row.goodwill-and-intangible-assets | 0 | 5235.1 | 1293.4 | 1332.6 | |||||
balance-sheet.row.long-term-investments | 0 | 309.5 | 316.4 | 346.4 | |||||
balance-sheet.row.tax-assets | 0 | 29.2 | 22.9 | 24.6 | |||||
balance-sheet.row.other-non-current-assets | 0 | -4488.3 | -512.8 | -512.8 | |||||
balance-sheet.row.total-non-current-assets | 0 | 2119.5 | 2171 | 2245.9 | |||||
balance-sheet.row.other-assets | 0 | 0 | 0 | 0 | |||||
balance-sheet.row.total-assets | 0 | 4746.2 | 4771 | 4796.4 | |||||
balance-sheet.row.account-payables | 0 | 163.2 | 207.3 | 203.2 | |||||
balance-sheet.row.short-term-debt | 0 | 449 | 182.4 | 150 | |||||
balance-sheet.row.tax-payables | 0 | 33.8 | 25.7 | 23.6 | |||||
balance-sheet.row.long-term-debt-total | 0 | 210.8 | 488.3 | 542 | |||||
Deferred Revenue Non Current | 0 | 1.4 | 1.1 | 0.5 | |||||
balance-sheet.row.deferred-tax-liabilities-non-current | 0 | - | - | - | |||||
balance-sheet.row.other-current-liab | 0 | 396.8 | 410 | 409.2 | |||||
balance-sheet.row.total-non-current-liabilities | 0 | 286.9 | 538.3 | 668.5 | |||||
balance-sheet.row.other-liabilities | 0 | 0 | 0 | 0 | |||||
balance-sheet.row.capital-lease-obligations | 0 | 14.2 | 15 | 9.1 | |||||
balance-sheet.row.total-liab | 0 | 1355.7 | 1391.3 | 1480.7 | |||||
balance-sheet.row.preferred-stock | 0 | 0 | 0 | 0 | |||||
balance-sheet.row.common-stock | 0 | 64.4 | 65.7 | 71.7 | |||||
balance-sheet.row.retained-earnings | 0 | 2625.8 | 2475.7 | 2381.5 | |||||
balance-sheet.row.accumulated-other-comprehensive-income-loss | 0 | 87.6 | 178.7 | 160.6 | |||||
balance-sheet.row.other-total-stockholders-equity | 0 | 386.7 | 394.2 | 430.3 | |||||
balance-sheet.row.total-stockholders-equity | 0 | 3164.5 | 3114.3 | 3044.1 | |||||
balance-sheet.row.total-liabilities-and-stockholders-equity | 0 | 4746.2 | 4771 | 4796.4 | |||||
balance-sheet.row.minority-interest | 0 | 217.6 | 255.5 | 257.3 | |||||
balance-sheet.row.total-equity | 0 | 3382.1 | 3369.8 | 3301.4 | |||||
balance-sheet.row.total-liabilities-and-total-equity | 0 | - | - | - | |||||
Total Investments | 0 | 358.1 | 387.6 | 414.7 | |||||
balance-sheet.row.total-debt | 0 | 674 | 685.6 | 701.1 | |||||
balance-sheet.row.net-debt | 0 | -417.6 | -400.4 | -468.9 |
Kasstroomoverzicht
common:word.in-mln USD Growth | TTM | 2022 | 2021 | 2020 | 2019 | |||
---|---|---|---|---|---|---|---|---|
cash-flows.row.net-income | 0 | 405.4 | 351.7 | 302.4 | ||||
cash-flows.row.depreciation-and-amortization | 0 | 118.9 | 113 | 102.2 | ||||
cash-flows.row.deferred-income-tax | 0 | -469.7 | -381.9 | -294.9 | ||||
cash-flows.row.stock-based-compensation | 0 | 91.8 | 76.5 | 30.7 | ||||
cash-flows.row.change-in-working-capital | 0 | -158.8 | -38.1 | -30.3 | ||||
cash-flows.row.account-receivables | 0 | -124.1 | -40.2 | -106.1 | ||||
cash-flows.row.inventory | 0 | -80.2 | -27.9 | -37.9 | ||||
cash-flows.row.account-payables | 0 | 64.1 | -11.2 | 84.1 | ||||
cash-flows.row.other-working-capital | 0 | -18.6 | 41.3 | 29.6 | ||||
cash-flows.row.other-non-cash-items | 0 | 341 | 337.5 | 281.5 | ||||
cash-flows.row.net-cash-provided-by-operating-activities | 0 | 0 | 0 | 0 | ||||
cash-flows.row.investments-in-property-plant-an-equipment | 0 | -166.2 | -180.2 | -146 | ||||
cash-flows.row.acquisitions-net | 0 | 4.9 | 219.6 | -19.6 | ||||
cash-flows.row.purchases-of-investments | 0 | -247.2 | -5.9 | -27.6 | ||||
cash-flows.row.sales-maturities-of-investments | 0 | 0.1 | 0.6 | 0.1 | ||||
cash-flows.row.other-investing-activites | 0 | 0 | 0.5 | 216.9 | ||||
cash-flows.row.net-cash-used-for-investing-activites | 0 | -408.3 | 34.6 | 23.8 | ||||
cash-flows.row.debt-repayment | 0 | -13.9 | -30.5 | -151.3 | ||||
cash-flows.row.common-stock-issued | 0 | -35.2 | 40.4 | 37.5 | ||||
cash-flows.row.common-stock-repurchased | 0 | -5.2 | -11.3 | -1.9 | ||||
cash-flows.row.dividends-paid | 0 | -110.4 | -101 | -101.6 | ||||
cash-flows.row.other-financing-activites | 0 | 40.3 | -176.3 | 10.5 | ||||
cash-flows.row.net-cash-used-provided-by-financing-activities | 0 | -124.5 | -278.7 | -206.9 | ||||
cash-flows.row.effect-of-forex-changes-on-cash | 0 | 96.2 | -54.4 | -57 | ||||
cash-flows.row.net-change-in-cash | 0 | -84 | 251.7 | 263.1 | ||||
cash-flows.row.cash-at-end-of-period | 0 | 1086 | 1170 | 918.3 | ||||
cash-flows.row.cash-at-beginning-of-period | 0 | 1170 | 918.3 | 655.2 | ||||
cash-flows.row.operating-cash-flow | 0 | 328.6 | 458.7 | 391.6 | ||||
cash-flows.row.capital-expenditure | 0 | -166.2 | -180.2 | -146 | ||||
cash-flows.row.free-cash-flow | 0 | 162.4 | 278.5 | 245.6 |
Rij winst-en-verliesrekening
common:word.in-mln USD Growth | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | |||
---|---|---|---|---|---|---|---|---|---|
income-statement-row.row.total-revenue | 0 | 1871.6 | 2027.3 | 2041.4 | |||||
income-statement-row.row.cost-of-revenue | 0 | 970.9 | 1005.8 | 942.3 | |||||
income-statement-row.row.gross-profit | 0 | 900.7 | 1021.6 | 1099.1 | |||||
income-statement-row.row.gross-profit-ratio | 0 | 0 | 0 | 0 | |||||
income-statement-row.row.research-development | 0 | - | - | - | |||||
income-statement-row.row.selling-general-administrative | 0 | - | - | - | |||||
income-statement-row.row.selling-and-marketing-expenses | 0 | - | - | - | |||||
income-statement-row.row.other-expenses | 0 | 6.6 | 10.3 | 10.9 | |||||
income-statement-row.row.operating-expenses | 0 | 581.1 | 566.3 | 622.9 | |||||
income-statement-row.row.cost-and-expenses | 0 | 1552 | 1572 | 1565.2 | |||||
income-statement-row.row.interest-income | 0 | 235.7 | 26.8 | 22.4 | |||||
income-statement-row.row.interest-expense | 0 | 273 | 28.5 | 21.7 | |||||
income-statement-row.row.selling-and-marketing-expenses | 0 | - | - | - | |||||
income-statement-row.row.total-other-income-expensenet | 0 | 4.7 | 27.4 | -42.1 | |||||
income-statement-row.row.ebitda-ratio-caps | 0 | - | - | - | |||||
income-statement-row.row.other-operating-expenses | 0 | 6.6 | 10.3 | 10.9 | |||||
income-statement-row.row.total-operating-expenses | 0 | 4.7 | 27.4 | -42.1 | |||||
income-statement-row.row.interest-expense | 0 | 273 | 28.5 | 21.7 | |||||
income-statement-row.row.depreciation-and-amortization | 0 | 128.2 | 118.9 | 113 | |||||
income-statement-row.row.ebitda-caps | 0 | - | - | - | |||||
income-statement-row.row.operating-income | 0 | 319.6 | 455.3 | 476.1 | |||||
income-statement-row.row.income-before-tax | 0 | 324.3 | 482.7 | 434 | |||||
income-statement-row.row.income-tax-expense | 0 | 43.5 | 63.2 | 64.9 | |||||
income-statement-row.row.net-income | 0 | 283.2 | 405.4 | 351.7 |
Vaak gestelde vragen
Wat is Shandong Weigao Group Medical Polymer Company Limited (SHWGF) totale activa?
Shandong Weigao Group Medical Polymer Company Limited (SHWGF) totale activa is 4746213417.000.
Wat is de jaarlijkse omzet van de onderneming?
De jaarlijkse omzet is N/A.
Wat is de winstmarge van de onderneming?
De bedrijfswinstmarge is 0.482.
Wat is vrije kasstroom van de onderneming?
De vrije kasstroom is {free_cash_flow}}.
Wat is de nettowinstmarge van de onderneming?
De nettowinstmarge is 0.152.
Wat is de totale omzet van de onderneming?
De totale opbrengst is 0.168.
Wat is Shandong Weigao Group Medical Polymer Company Limited (SHWGF) nettowinst (netto-inkomen)?
De nettowinst is 283215434.000.
Wat is de totale schuld van het bedrijf?
De totale schuld is 674011810.000.
Wat zijn de bedrijfskosten?
De bedrijfsuitgaven zijn 581122121.000.
Wat is het kasstroomcijfer van het bedrijf?
Enretprise cash is 0.000.